Table 1.
Demographic and Clinical Characteristics of Patients
| N=30 | |
|---|---|
| Male sex | 29 (96.7) |
| Age, y | 62.8±8.5 |
| Weight, kg | 80.1±9.8 |
| Body mass index, kg/m² | 28.0±3.1 |
| Hyperlipidemia | 11 (36.7) |
| Hypertension | 12 (40.0) |
| Diabetes mellitus | 12 (40.0) |
| Current smoker | 23 (76.7) |
| Prior myocardial infarction | 10 (33.3) |
| Prior PCI | 9 (30.0) |
| Clinical presentation | |
| STEMI | 9 (30.0) |
| NSTE‐ACS | 10 (33.3) |
| Stable angina/ischemia in provocative test | 11 (36.7) |
| Medication | |
| Aspirin | 24 (80.0) |
| P2Y12 receptor antagonist | 11 (36.7) |
| Statin | 22 (73.3) |
| Calcium channel blocker | 4 (13.3) |
| Nitrate | 4 (13.3) |
| β‐Blocker | 21 (70.0) |
| Proton‐pump inhibitors | 15 (50.0) |
| Angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker | 10 (33.3) |
| Insulin | 2 (6.7) |
| Oral hypoglycemic agent | 8 (26.7) |
| Laboratory evaluation | |
| Hematocrit, % | 41.4±3.9 |
| Platelets, ×1000/mm³ | 225.6±86.5 |
| Creatinine clearance, mL/min (Cockroft–Gault formula) | 91.8±25.4 |
Values are expressed as means±SD or n (%). NSTE‐ACS indicates non ST elevation acute coronary syndrome; PCI, percutaneous coronary intervention; STEMI, ST‐segment elevation myocardial infarction.